Robertson Stephens Wealth Management, LLC Adaptive Biotechnologies Corp Transaction History

Robertson Stephens Wealth Management, LLC

$2.84 Billion
Q1 2025

A detailed history of Robertson Stephens Wealth Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Robertson Stephens Wealth Management, LLC holds 167,936 shares of ADPT stock, worth $1.66 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

167,936

Previous 172,186 2.47%

Holding current value

$1.66 Million

Previous $1.03 Million 20.72%

% of portfolio

0.04%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	SELL	$6.07 - $8.66 $25,797 - $36,805	-4,250 Reduced 2.47%	167,936 $1.25 Million
Q4 2024 Jan 27, 2025	SELL	$4.37 - $6.78 $50,255 - $77,970	-11,500 Reduced 6.26%	172,186 $1.03 Million
Q3 2024 Nov 12, 2024	SELL	$3.37 - $5.12 $337 - $512	-100 Reduced 0.05%	183,686 $940,000
Q4 2023 Feb 06, 2024	SELL	$3.46 - $5.33 $55,360 - $85,280	-16,000 Reduced 8.01%	183,786 $900,000
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $18,105 - $25,681	-2,925 Reduced 1.44%	199,786 $1.34 Million
Q1 2023 May 11, 2023	BUY	$7.8 - $10.11 $163,800 - $212,310	21,000 Added 11.56%	202,711 $1.79 Million
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $2,817 - $4,203	-450 Reduced 0.25%	181,711 $1.39 Million
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $2,880 - $6,628	450 Added 0.25%	182,161 $1.47 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $42,251 - $120,657	4,175 Added 2.35%	181,711 $2.52 Million
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $50,340 - $73,700	-2,000 Reduced 1.11%	177,536 $4.98 Million
Q2 2021 Aug 17, 2021	SELL	$32.22 - $44.59 $225,540 - $312,130	-7,000 Reduced 3.75%	179,536 $7.34 Million
Q1 2021 May 07, 2021	SELL	$37.26 - $67.74 $946,404 - $1.72 Million	-25,400 Reduced 11.98%	186,536 $7.51 Million
Q4 2020 Feb 10, 2021	SELL	$45.01 - $65.47 $2.58 Million - $3.75 Million	-57,250 Reduced 21.27%	211,936 $12.5 Million
Q3 2020 Nov 10, 2020	SELL	$35.79 - $48.81 $7.51 Million - $10.2 Million	-209,793 Reduced 43.8%	269,186 $13.1 Million
Q2 2020 Aug 12, 2020	SELL	$24.95 - $48.38 $1.45 Million - $2.81 Million	-58,116 Reduced 10.82%	478,979 $23.2 Million
Q1 2020 May 01, 2020	BUY	$16.96 - $34.16 $6.85 Million - $13.8 Million	404,179 Added 304.09%	537,095 $14.9 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $3.26 Million - $4.36 Million	132,916 New	132,916 $3.98 Million

Others Institutions Holding ADPT

# of Institutions

246

Shares Held

156M

Call Options Held

44.3K

Put Options Held

47.8K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.41B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robertson Stephens Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robertson Stephens Wealth Management, LLC with notifications on news.

Account

Robertson Stephens Wealth Management, LLC Adaptive Biotechnologies Corp Transaction History